Peripartum cardiomyopathy

Progress in Cardiovascular Diseases

Volumn 27, Issue 4, 1985, Pages 223-240

  Julian, Desmond G ^a   Szekely, Paul ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DISOPYRAMIDE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; HYDRALAZINE; NITRATE; PRAZOSIN; PREDNISONE; SALBUTAMOL; VERAPAMIL;

DIAGNOSIS; DRUG THERAPY; EPIDEMIOLOGY; ETIOLOGY; HEART; HEART FAILURE; HISTOPATHOLOGY; HUMAN; POSTPARTUM CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; REVIEW; THERAPY;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MYOCARDIAL DISEASES; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY TRIMESTER, THIRD; PROGNOSIS; PUERPERIUM; SYNDROME;

EID: 0021910163     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/0033-0620(85)90007-6     Document Type: Article

References (132)

1. Idiopathic myocardial failure in the last trimester of pregnancy and the puerperium
2. Toxic post-partal heart failure
3. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium
4. Uncommon myocardial diseases. The non-coronary cardiomyopathies
5. Puerperal cardiomyopathy
6. Post-partal heart disease
7. “Post-partal” heart disease—a syndrome
8. Post-partum heart disease
9. Postpartal heart disease
10. Idiopathic myocardiopathy of the puerperium (postpartal heart disease)
11. The frontiers of cardiomyopathies
12. The effect of prolonged bed rest on postpartal cardiomyopathy
13. Peripartum cardiomyopathy
14. Cardiomyopathy of pregnancy and the puerperium
15. Post-partum heart disease
16. Myocardie et etat gravido-puerpéral
17. Acute congestive cardiac failure of unknown etiology in pregnancy
18. Cardiological problems in younger women including those of pregnancy and the puerperium
19. Congestive and hypertrophic cardiomyopathies A decade of study
20. Cardiomyopathy of pregnancy
21. Cardiomyopathy and pregnancy
22. A case of fatal peripartum cardiomyopathy
23. Cardiomyopathy and renal failure occurring in the puerperium
24. The cardiomyopathies
25. Problémes de la myocardiopathie du post-partum
26. Maternal cardiomyopathy of pregnancy causing stillbirth
27. Maternity and myocardial failure in African women
28. Postpartum hypertensive heart failure
29. Adult heart disease in Western Nigeria. A clinico-pathological synopsis
30. The evolution of peripartal heart failure in Zaria, Nigeria
31. Peripartum cardiac failure
32. The etiology of peripartum cardiac failure
33. Postpartum cardiac failure—heart failure due to volume over-load
34. Clarification of cardiomyopathies
35. The maternal heart in the postpartum period
36. The heart and pregnancy
37. Pregnancy and cardiovascular disease
38. Cardiac changes in pregnancy unrelated to the normal etiological types of heart disease
39. Hypertension six weeks postpartum in apparently normal patients
40. Adult heart disease due to coxsackie virus group B
41. Myocarditis and cardiomyopathy after arbovirus infection (dengue and chikungunya fever)
42. Heart disease caused by coxsackie virus B infection
43. Antibodies to coxsackie B viruses in congestive cardiomyopathy
44. Post-carditic myocardiopathy
45. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy
46. Acute isolated myocarditis in pregnancy
47. Acute fulminating puerperal myocarditis
48. Peripartum cardiomyopathy due to myocarditis
49. Trophoblast in the circulating blood during pregnancy
50. Immunologic fingdings in idiopathic cardiomyopathy: a prospective serial study
51. Heart antibodies in cardiomyopathies
52. Immunoglobulin binding in cardiomyopathic hearts
53. The cardiomyopathies and myocarditides
54. Familial occurrence of postpartal heart failure
55. Familial cardiomegaly
56. Cardiomyopathy in four members of a family
57. Familial cardiomyopathies
58. Seasonal variations of cardiac failure in Northern Nigeria
59. Heart disease and pregnancy
60. Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy
61. Myocarditis of obscure etiology associated with pregnancy
62. Idiopathic heart disease associated with pregnancy and the puerperium
63. Idiopathic post-partum cardiomyopathy. Report of a case with special reference to its ultrastructural changes in the myocardium as studies by endomyocardial biopsy
64. Natural course of peripartum cardiomyopathy
65. Importance of cardiomyopathy and cerebral lischaemia in the diagnosis of fatal coma in pregnancy
66. Fatal brain damage associated with cardiomyopathy of pregnancy, with notes on caesarean section in a hyperbaric chamber
67. Clinical aspects of cardiomyopathy
68. Value and limitations of two-dimensional echocardiography in assessment of cardiomyopathy
69. Cardiomyopathies
70. Fibrinolysis in normal pregnancy
71. The ECG in normal pregnancy
72. Haemodynamic effects of pregnancy in patients with heart failure
73. Is the inotropic effect of digoxin maintained? An illustrative case report
74. Influence of digitalis on time of onset and duration of labour in women with cardiac disease
75. Serum digoxin concentrations in the human fetus, neonate and infant
76. Transplacental neonatal digitalis intoxication
77. The management of congestive heart failure
78. The role of vasodilator therapy in heart failure
79. Vasodilator treatment for acute and chronic heart failure
80. Hydralazine in the management of left ventricular failure
81. Long-term therapy of heart failure with prazosin. A randomised double-blind trial
82. Results of long-term vasodilator therapy in patients with refractory congestive heart failure
83. Effectiveness of long-term vasodilator administration in the treatment of left ventricular failure
84. Acute hemodynamic responses to vasodilator therapy in congestive heart failure
85. Acute pulmonary edema in the obstetrical patient the use of hemodynamic monitoring
86. Hemodynamic monitoring of cardiogenic pulmonary edema complicating toxemia of pregnancy
87. Invasive hemodynamic monitoring in critically ill pregnant patients: role of Swan-Ganz catheterization
88. Beneficial effects of salbutamol on cardiac function in severe congestive cardiomyopathy
89. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade
90. Double-blind trial of chronic oral beta-blockade in congestive cardiomyopathy
91. Is there autonomic impairment in congestive (dilated) cardiomyopathy?
92. Dopamine—clinical uses of an endogenous catecholamine
93. Dopamine influence on human uterine activity at term pregnancy
94. Dobutamine: a new cardioactive sympathetic amine
95. Mechanical circulatory assistance with the intra-aortic balloon pump and other counterpulsation devices
96. Cardiac transplantation in 150 patients at Stanford University
97. Prospects and predictions for the cardiomyopathies
98. May mothers given warfarin breast-feed their infants?
99. A fresh look at cardiac arrhythmias. Therapy
100. Electrical reversion of cardiac arrhythmias
101. Direct current shock and digitalis
102. Cardioversion and defibrillation
103. Initiation of uterine contractions by disopyramide during pregnancy
104. Mexiletine for control of ventricular dysrhythmias in pregnancy
105. Ventricular tachycardia in four patients evaluated by programmed electrical stimulation of the heart and treated in two patients by surgical division of anterior radiation of left bundle-branch
106. The treatment of supraventricular arrhythmias
107. A current appraisal of the cardiomyopathies
108. Arrhythmias in hypertrophic cardiomyopathy. I. Influence and prognosis
109. Arrhythmia as a cause of sudden death in hypertrophic cardiomyopathy
110. Sudden death in hypertrophic cardiomyopathy. A profile of 78 patients
111. Cardiac arrhythmia in hypertrophic cardiomyopathy
112. Management of pregnancy complicated by hypertrophic obstructive cardiomyopathy
113. Management of pregnancy in patients with hypertrophic cardiomyopathy
114. Arrhythmia in hypertrophic cardiomyopathy. II. Comparison of amiodarone and verapamil in treatment
115. Treatment of hypertrophic obstructive cardiomyopathy with verapamil
116. Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy
117. Verapamil in the treatment of hypertrophic cardiomyopathy
118. Heart disease and pregnancy
119. Mitral valve prolapse in one hundred presumably healthy females
120. Arrhythmias on exercise in patients with abnormalities of the posterior leaflet of the mitral valve
121. Arrhythmias in patients with mitral valve prolapse
122. Ventricular arrhythmias in syndrome of balloon deformity of mitral valve. Definition of possible high risk group
123. Mild mitral regurgitation and the mitral prolapse fiasco
124. The effect of pregnancy on the midsystolic click and murmur of the prolapsing posterior leaflet of the mitral valve
125. A controlled evaluation of the risk of bacterial endocarditis in persons with mitral valve prolapse